Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector
- PMID: 25121209
- Bookshelf ID: NBK232165
- DOI: 10.17226/4906
Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector
Excerpt
Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have an enormous impact on the medical consequences and socioeconomic problems associated with drug abuse, both for drug-dependent individuals and for American society as a whole. This book examines the current environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions, and proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.
Copyright 1995 by the National Academy of Sciences. All rights reserved.
Sections
- COMMITTEE TO STUDY MEDICATION DEVELOPMENT AND RESEARCH AT THE NATIONAL INSTITUTE ON DRUG ABUSE
- Acknowledgments
- Preface
- Note to the Reader
- Executive Summary
- 1. Introduction
- 2. Overview of the State of Scientific Knowledge Concerning Drug Addiction
- 3. Assessment of the Medications Development Division
- 4. Treatment Setting and Effectiveness
- 5. Treatment Financing and Trends in Health Insurance
- 6. Training and Education
- 7. Federal Laws and Regulations
- 8. State Laws and Regulations
- 9. Market Obstacles and Creating Incentives
- Appendix A Acknowledgements
- Appendix B Organization and Mission Statements of NIDA's Medications Development Division and Its Branches
- Appendix C Diagnostic Criteria for Psychoactive Substance Dependence
- Appendix D Survey of Pharmaceutical Companies
- Appendix E Model Federal Programs in Pharmaceutical R&D
- Appendix F Workshop Agenda and Participants
- Appendix G Health Care Reform Legislation
- Appendix H Acronyms
Publication types
LinkOut - more resources
Full Text Sources
